Search Results 591-600 of 24243 for In situ
... in treating patients with upper urinary tract cancer. Immunotherapy with ... situ breast, cervical or other in situ carcinoma, and either clinically ...
The Immunostains lab performs immunohistochemistry (IHC), in-situ hybridization (ISH) and mass spectrometry-based proteomic (MS) clinical diagnosis tests.
Targeted therapy uses medicines that attack specific chemicals in the cancer cells. By blocking these chemicals, targeted treatments can cause cancer cells to ...
superficial bladder cancer, or carcinoma in situ of the prostate, cervix, or breast. - Any of the following cardiac abnormalities - Uncontrolled ...
... in situ cervical carcinoma) within 5 years prior to screening. Subject has participated in another clinical study within 90 days prior to signing the ...
... in situ cervical cancer, early-stage endometrial cancer, Gleason 6/7 prostate cancer, ductal carcinoma in situ, or lobular carcinoma in situ of the breast.
Evidence of other active, invasive malignancy requiring treatment within the past 5 years. Noninvasive cancer history (such as carcinoma-in-situ [CIS] that has ...
Radiation Therapy with or without Cetuximab in Treating Patients Who Have Undergone Surgery for Locally Advanced Head and Neck Cancer ... in situ of the breast, ...
Our overarching hypothesis is that management of low-risk Ductal Carcinoma in Situ (DCIS) using an AS approach does not yield inferior cancer or quality of life ...
Drugs used in chemotherapy, such as lenalidomide and dexamethasone, work in ... NOTE: Patients with nonmelanoma skin cancer or carcinoma in situ of any type are ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.